Home › Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research
 

Keywords :   


Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research

2015-11-25 01:19:03| drugdiscoveryonline Home Page

Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that Infinity Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the discovery, development and delivery of medicines for difficult-totreat diseases, has expanded its use of the Medidata Clinical Cloud.

Tags: research selected solution advance

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »